Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 1998, p. 3006-3008, Vol. 42, No. 11
Unité de la Tuberculose et des
Mycobactéries, Institut Pasteur, Morne Jolivière, BP
484, 97165 Pointe-à-Pitre, Guadeloupe
Received 16 June 1998/Returned for modification 4 August
1998/Accepted 1 September 1998
We investigated the postantibiotic effects (PAEs) of four agents
against Mycobacterium avium in a human macrophage model
under two different experimental conditions. For postantibiotic
leukocyte enhancement (PALE), bacteria were exposed to antibiotics
prior to their phagocytosis, whereas for pulsed exposure (PE),
antibiotics were added after phagocytosis. In both cases, the drugs
were used at their peak concentrations in serum
(Cmax) for 2 h. The results showed two
different patterns: one for the drug for which results under PE and
PALE test conditions did not significantly differ (amikacin) and one
for drugs for which PAE values were significantly higher under PE test
conditions (clarithromycin, clofazimine, and rifampin). These data
suggest that even a brief exposure of M. avium to peak
concentrations of certain drugs in serum may result in prolonged and
persistent suppression of bacterial growth inside human macrophages.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Pulsed-Exposure and Postantibiotic Leukocyte
Enhancement Effects of Amikacin, Clarithromycin, Clofazimine, and
Rifampin against Intracellular Mycobacterium avium
*
Corresponding author. Mailing address: Institut
Pasteur, Morne Jolivière, BP 484, F-97165 Pointe-à-Pitre
Cedex, Guadeloupe. Phone: 590-893-881. Fax: 590-893-880. E-mail:
rastogi{at}ipagua.gp.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»